Consultant eye surgeon Alex Shortt will be delivering a talk on the use of cell therapy in tackling corneal disease at the BCLA’s upcoming evening meeting.

Shortt will lead the meeting with a discussion about his 10 year research on the development of cell therapies for corneal and conjunctival disease.

He said: ‘My goal is to improve the lives of patients with chronic, severe ocular surface disease through the delivery of novel cellular therapies using different therapeutic cell types.’

Delegates attending the evening meeting will, pending approval, receive one CET point.

Free for BCLA members, the event will be held at The Royal College of Surgeons in London on March 23.